OLD National Bancorp IN boosted its holdings in shares of Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 2.9% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 261,317 shares of the company's stock after purchasing an additional 7,326 shares during the period. OLD National Bancorp IN's holdings in Roche were worth $10,604,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Rhumbline Advisers lifted its stake in Roche by 7.4% during the first quarter. Rhumbline Advisers now owns 107,252 shares of the company's stock worth $4,413,000 after purchasing an additional 7,374 shares during the last quarter. Altrius Capital Management Inc increased its holdings in shares of Roche by 3.6% during the first quarter. Altrius Capital Management Inc now owns 189,993 shares of the company's stock worth $7,818,000 after buying an additional 6,545 shares in the last quarter. Everett Harris & Co. CA acquired a new position in shares of Roche during the first quarter worth $445,000. Bard Financial Services Inc. increased its holdings in shares of Roche by 25.3% during the first quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock worth $5,716,000 after buying an additional 28,050 shares in the last quarter. Finally, Riverbridge Partners LLC increased its holdings in shares of Roche by 6.7% during the first quarter. Riverbridge Partners LLC now owns 37,826 shares of the company's stock worth $1,557,000 after buying an additional 2,381 shares in the last quarter.
Roche Trading Up 1.3%
Shares of Roche stock opened at $45.30 on Friday. The business has a 50-day moving average price of $40.76 and a two-hundred day moving average price of $40.25. Roche Holding AG has a 1-year low of $34.10 and a 1-year high of $45.46.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on RHHBY. Hsbc Global Res upgraded shares of Roche from a "hold" rating to a "strong-buy" rating in a report on Thursday. HSBC upgraded shares of Roche from a "hold" rating to a "buy" rating and set a $50.00 price target for the company in a report on Thursday. Three investment analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $50.00.
Read Our Latest Analysis on Roche
Roche Profile
(
Free Report)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Roche, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Roche wasn't on the list.
While Roche currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.